Rituximab maintenance therapy in diffuse large B-cell lymphoma in a multicenter prospective randomised phase II study

被引：0
|
作者：
Witzens-Harig, M. [1 ]
Benner, A. [2 ]
Rieger, M.
McClanahan, F. [1 ]
Hensel, M.
Neben, K. [1 ]
Dreger, P. [1 ]
Lengfelder, E. [3 ]
Schmidt-Wolf, I [4 ]
Kraemer, A. [1 ]
Ho, A. D. [1 ]
机构：
[1] Univ Heidelberg, Med Klin 5, Heidelberg, Germany
[2] German Canc Res Ctr, D-6900 Heidelberg, Germany
[3] Univ Heidelberg, Med Fac Mannheim, D-6800 Mannheim, Germany
[4] Univ Bonn, CIO, Bonn, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [31] Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India
    Patel, Ankit
    Bhatt, Niraj
    Prakash, S. S.
    Biswas, Ghanashyam
    Nagarkar, Rajnish
    Roy, Bodhisatta
    Samal, Priyanka
    Agrawal, Narendra
    Meshram, Sushil
    Kaushal, Ashish
    Satheesh, C. T.
    Wategaonkar, Ravikumar
    Thiagarajan, Kasi Viswanathan
    Jain, Kartikeya
    Vijayaveeran, P.
    Mukherjee, Kalyan
    Singh, Kishore
    Patil, Tushar
    Jain, Amit
    Dolai, Tuphan Kanti
    Jain, Minish
    Hingmire, Sachin
    Gupta, Tara Chand
    Lakshmaiah, K. C.
    Rajamanickam, Deepan
    Nemade, Bhushan
    Goyal, Vikash
    Mahato, Pinaki
    Mendiratta, Sanjeev Kumar
    Doshi, Maulik
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 91 (06) : 457 - 468
  • [32] Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India
    Ankit Patel
    Niraj Bhatt
    S. S. Prakash
    Ghanashyam Biswas
    Rajnish Nagarkar
    Bodhisatta Roy
    Priyanka Samal
    Narendra Agrawal
    Sushil Meshram
    Ashish Kaushal
    C. T. Satheesh
    Ravikumar Wategaonkar
    Kasi Viswanathan Thiagarajan
    Kartikeya Jain
    P. Vijayaveeran
    Kalyan Mukherjee
    Kishore Singh
    Tushar Patil
    Amit Jain
    Tuphan Kanti Dolai
    Minish Jain
    Sachin Hingmire
    Tara Chand Gupta
    K. C. Lakshmaiah
    Deepan Rajamanickam
    Bhushan Nemade
    Vikash Goyal
    Pinaki Mahato
    Sanjeev Kumar Mendiratta
    Maulik Doshi
    Cancer Chemotherapy and Pharmacology, 2023, 91 : 457 - 468
  • [33] Efficacy of Rituximab Maintenance for Diffuse Large B Cell Lymphoma with Transformation
    Uryu, Hideki
    Mishima, Yuko
    Yokoyama, Masahiro
    Nishimura, Noriko
    Kusano, Yoshiharu
    Inoue, Norihito
    Nishihara, Anna
    Fukuta, Takanori
    Shirouchi, Yuko
    Tsuyama, Naoko
    Takeuchi, Kengo
    Terui, Yasuhito
    BLOOD, 2018, 132
  • [34] Rituximab maintenenance therapy in CD20+B-cell Non-Hodgkin-Lymphoma - Final results of a multicenter prospective randomised phase II study
    Witzens-Harig, M.
    Benner, A.
    Rieger, M.
    McClanahan, F.
    Hensel, M.
    Neben, K.
    Dreger, P.
    Lengfelder, E.
    Schmidt-Wolf, I
    Kraemer, A.
    Ho, A.
    ONKOLOGIE, 2010, 33 : 204 - 204
  • [35] A phase II randomized study of lenalidomide or lenalidomide and rituximab as maintenance therapy following standard chemotherapy for patients with high/high-intermediate risk diffuse large B-cell lymphoma
    Reddy, N. M.
    Greer, J. P.
    Morgan, D. S.
    Chen, H.
    Park, S. I.
    Richards, K. L.
    LEUKEMIA, 2017, 31 (01) : 241 - 244
  • [36] A phase II randomized study of lenalidomide or lenalidomide and rituximab as maintenance therapy following standard chemotherapy for patients with high/high-intermediate risk diffuse large B-cell lymphoma
    N M Reddy
    J P Greer
    D S Morgan
    H Chen
    S I Park
    K L Richards
    Leukemia, 2017, 31 : 241 - 244
  • [37] Safety and Clinical Activity of Temsirolimus in Combination with Rituximab and DHAP in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Report of the Prospective, Multicenter Phase II STORM Trial
    Witzens-Harig, Mathias
    Viardot, Andreas
    Keller, Ulrich
    Buske, Christian
    Crombe, Anne
    Hoenig, Elisabeth
    Atta, Johannes
    Schmier, Johann
    Meissner, Julia
    Ho, Anthony D.
    LaRosee, Paul
    Marks, Reinhard
    Dreyling, Martin
    Hess, Georg
    BLOOD, 2016, 128 (22)
  • [38] Treatment of primary gastric diffuse large-cell lymphoma with Rituximab and CHOP. Preliminary results of a prospective, multicenter phase II study
    Brugger, W
    Jakob, A
    Guenther, E
    Schlimok, G
    Sandherr, M
    ANNALS OF ONCOLOGY, 2005, 16 : 162 - 162
  • [39] Ocular Adnexal Diffuse Large B-cell Lymphoma A Multicenter International Study
    Munch-Petersen, Helga D.
    Rasmussen, Peter K.
    Coupland, Sarah E.
    Esmaeli, Bita
    Finger, Paul T.
    Graue, Gerardo F.
    Grossniklaus, Hans E.
    Honavar, Santosh G.
    Khong, Jwu Jin
    McKelvie, Penny A.
    Mulay, Kaustubh
    Prause, Jan U.
    Ralfkiaer, Elisabeth
    Sjo, Lene D.
    Sniegowski, Matthew C.
    Vemuganti, Geeta K.
    Heegaard, Steffen
    JAMA OPHTHALMOLOGY, 2015, 133 (02) : 165 - 173
  • [40] Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
    Habermann, Thomas M.
    Weller, Edie A.
    Morrison, Vicki A.
    Gascoyne, Randy D.
    Cassileth, Peter A.
    Cohn, Jeffrey B.
    Dakhil, Shaker R.
    Woda, Bruce
    Fisher, Richard I.
    Peterson, Bruce A.
    Horning, Sandra J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3121 - 3127
12345